Tickers

1. Composite Trajectory Verdict

All three statements carry weight: the income statement shows whether the core PPS-and-Automation model generates profit, the cash flow statement reveals if that model funds its own converter-fleet investment and debt service, and the balance sheet tracks the leverage and liquidity cushion supporting the capital-intensive installed base.

Composite Trajectory: Mixed

The annual 2025 results deteriorated: revenue grew 7.1% but gross profit fell 6.5% (margin 33.1% vs 37.9%), operating loss nearly doubled to -$24.3M, and net loss widened to -$38.3M (10-K FY2025, Consolidated Statements of Operations). Operating cash flow dropped 44% to $23.1M (10-K FY2025, Consolidated Statements of Cash Flows). Cash fell from $76.1M to $63.0M while debt remained ~$402M (10-K FY2025, Consolidated Balance Sheets). However, the most recent six months (YTD Q2 2026) show revenue up 12.5%, gross margin improving to 33.6% from 32.6%, operating loss narrowing to -$6.2M from -$17.7M, and operating cash flow turning positive $7.1M vs -$4.9M (10-Q Q2 2026, Consolidated Statements of Operations and Cash Flows). The improvement in recent quarters offsets the full-year 2025 decline, yielding a mixed overall picture.

2. Red Flags

• GAAP net loss widened 78% YoY in FY2025 despite 7.1% revenue growth (10-K FY2025, Consolidated Statements of Operations: -$38.3M vs -$21.5M).
• Gross margin compressed 480 bps in FY2025 (33.1% vs 37.9%) as cost of sales rose 15.4% vs revenue 7.1% (10-K FY2025, MD&A Consolidated Results).
• Operating cash flow fell 44% in FY2025 to $23.1M from $41.4M, driven by higher net loss and working capital builds (10-K FY2025, Consolidated Statements of Cash Flows).
• Cash balance has declined sequentially from $76.1M (Dec 2024) to $63.0M (Dec 2025) to $43.2M (Jun 2026) (10-K FY2025 and 10-Q Q2 2026, Consolidated Balance Sheets).
• Interest expense rose 19.9% in FY2025 to $34.3M (10-K FY2025, MD&A Interest Expense) and remains ~$16.7M per half-year (10-Q Q2 2026, Consolidated Statements of Operations), consuming a large share of operating cash flow.
• Goodwill impairment risk flagged for North America: fair value "close to approximating carrying value"; a 1.8% revenue growth reduction, 3.1% gross margin decline, or 1.3% discount rate increase would trigger impairment (10-K FY2025, Critical Accounting Policies).
• Warrant provisions to Amazon and Walmart reduce revenue non-cash: $5.1M provision in FY2025 (10-K FY2025, Reconciliation of GAAP to Non-GAAP) and $3.4M in H1 2026 (10-Q Q2 2026, Reconciliation), growing each period.
• Foreign currency swings materially distort comparability: FY2025 foreign currency gain $5.3M vs $1.6M in FY2024; H1 2026 foreign currency loss $1.5M vs gain $5.2M in H1 2025 (10-K FY2025 and 10-Q Q2 2026, Consolidated Statements of Operations).
• PPS installed base declined in H1 2026: total systems fell 2.3% to 141.7k from 145.0k a year earlier (10-Q Q2 2026, MD&A Key Performance Indicators).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

Annual FY2025 shows clear deterioration: net revenue rose to $395.0M from $368.9M, but gross profit fell to $130.7M from $139.8M, loss from operations widened to -$24.3M from -$12.8M, and net loss deepened to -$38.3M from -$21.5M (10-K FY2025, Consolidated Statements of Operations). By contrast, the most recent six months (H1 2026 vs H1 2025) show improvement: revenue $206.4M vs $183.5M (+12.5%), gross profit $69.4M vs $59.8M (+16.1%), loss from operations -$6.2M vs -$17.7M, and net loss -$18.1M vs -$18.4M (10-Q Q2 2026, Consolidated Statements of Operations). Q2 2026 alone had revenue $105.2M vs $92.3M, gross profit $34.5M vs $28.9M, and operating loss -$2.4M vs -$9.7M (10-Q Q2 2026, Consolidated Statements of Operations). The gap between GAAP net loss and non-GAAP AEBITDA remains wide (FY2025 AEBITDA $79.2M vs net loss -$38.3M; H1 2026 AEBITDA $38.0M vs net loss -$18.1M) (10-K FY2025 and 10-Q Q2 2026, Reconciliation of GAAP to Non-GAAP Measures).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Mixed

FY2025 operating cash flow dropped to $23.1M from $41.4M in FY2024 (10-K FY2025, Consolidated Statements of Cash Flows). Investing outflows were steady at -$32.8M vs -$32.5M (converter equipment and Pickle investments). Financing was -$7.0M vs +$1.8M (debt repayment vs prior year refinancing). Net cash fell -$13.1M to $63.0M (10-K FY2025, Consolidated Statements of Cash Flows). In H1 2026, operating cash flow improved to +$7.1M from -$4.9M in H1 2025, helped by lower inventory build (10-Q Q2 2026, Consolidated Statements of Cash Flows). Investing outflows rose to -$24.9M from -$19.8M, including $10.0M for a Pickle SAFE note (10-Q Q2 2026, MD&A Cash Flows). Financing was -$1.1M vs -$4.9M. Net cash decreased -$19.8M to $43.2M (10-Q Q2 2026, Consolidated Statements of Cash Flows). Free cash flow (operating minus investing) was -$9.7M in FY2025 and -$17.8M in H1 2026.

5. Balance Sheet Assessment

Balance Sheet Trajectory: Deteriorating

Cash declined from $76.1M (Dec 2024) to $63.0M (Dec 2025) to $43.2M (Jun 2026) (10-K FY2025 and 10-Q Q2 2026, Consolidated Balance Sheets). Total debt (including finance leases and financing arrangements, excl. deferred financing costs) was $410.5M at Dec 2025 and $410.6M at Jun 2026 (10-K FY2025 MD&A Liquidity; 10-Q Q2 2026 MD&A Debt Profile). Shareholders' equity fell from $548.1M to $534.9M to $519.9M over the same periods, driven by accumulated deficit growth (-$145.3M to -$183.6M to -$201.7M) (10-K FY2025 and 10-Q Q2 2026, Consolidated Balance Sheets). Accounts receivable rose from $43.9M to $47.7M to $49.4M; inventory from $21.7M to $30.6M to $32.7M; accounts payable from $26.9M to $36.7M to $36.5M (10-K FY2025 and 10-Q Q2 2026, Consolidated Balance Sheets). Goodwill decreased slightly from $443.7M to $457.2M to $454.0M (currency effect). No revolving facility drawn; $44.1M availability at Dec 2025, $47.2M at Jun 2026 (10-K FY2025 and 10-Q Q2 2026, MD&A Debt Profile).

6. Data Gaps

• Standalone Q3 2026 and Q4 2026 results (not yet filed) to complete FY2026 annual trend.
• Full-year 2026 segment EBITDA and capital expenditure breakdown (only H1 2026 provided in 10-Q Q2 2026).
• Detailed working capital component changes for Q1 2026 and Q2 2026 individually (only H1 aggregates in 10-Q Q2 2026).
• Interest rate swap expiration impact on FY2025 interest expense (referenced but not quantified in isolation).
• Reconciliation of "Other adjustments" in AEBITDA for H1 2026 (described as "insignificant items" without detail).